New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 24, 2014
09:09 EDTKOOLCesca Therapeutics, Cook Medical enter supply agreement for Phase 1b trial
Cesca Therapeutics announced today that they have entered a supply agreement with Cook Medical. Under the terms of the agreement, Cook Medical has been chosen as the supplier for select delivery device products for the Acute Myocardial Infarction Rapid Stem cell Therapy, or AMIRST, Phase 1b trial set to begin later this calendar year. The clinical trial is for targeted marketing approval in the United States, European Union Community and India.
News For KOOL From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
November 20, 2014
06:09 EDTKOOLCesca Therapeutics files IDE application for no-option critical limb ischemia
Cesca Therapeutics has submitted an investigational device exemption application to the FDA for a pivotal multicenter study of the company's SurgWerks-CLI and VXP System for treating advanced stages of no-option lower limb critical limb ischemia. The IDE application is the result of two prior positive pilot and feasibility studies conducted in Italy and India, respectively, and collaborative pre-IDE feedback from the U.S. FDA. The primary endpoint is major amputation free survival at 12 months following enrollment.
November 13, 2014
16:02 EDTKOOLCesca Therapeutics reports Q1 EPS (8c), consensus (7c)
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use